Home › Funds › SABBY MANAGEMENT, LLC › BCTXZ
SABBY MANAGEMENT, LLC position in BCTXZ
BRIACELL THERAPEUTICS CORP · Health Care
SABBY MANAGEMENT, LLC reported holding 120,802 shares of BCTXZ (BRIACELL THERAPEUTICS CORP) in its Q2 2026 13F filing — a position valued at US$11K, representing 0.08% of its reported portfolio and ranking #18 among its reported holdings. SABBY MANAGEMENT, LLC has disclosed BCTXZ holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SABBY MANAGEMENT, LLC's BCTXZ position evolved
SABBY MANAGEMENT, LLC first disclosed a stake in BCTXZ in Q2 2025 at 598,743 shares (US$635K). Across 5 filings, SABBY MANAGEMENT, LLC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 120,802 shares valued at US$11K — a reduction of -85,951 shares quarter over quarter.. Notable position changes include a 37% trim in Q3 2025, a 29% trim in Q4 2025, a 42% trim in Q2 2026.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 598.74K | $634.67K | New |
| Q3 2025 | 374.49K | $125.45K | Reduce |
| Q4 2025 | 265.96K | $77.18K | Reduce |
| Q1 2026 | 206.75K | $28.95K | Reduce |
| Q2 2026 | 120.80K | $11.46K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BCTXZ and 13F data
BCTXZ (BRIACELL THERAPEUTICS CORP) is a Health Care company. 4 other funds we track also report a position in BCTXZ. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BCTXZ
No other tracked fund reports a position in BCTXZ.
More on SABBY MANAGEMENT, LLC
FAQ
How long has SABBY MANAGEMENT, LLC held BCTXZ?
SABBY MANAGEMENT, LLC has disclosed BCTXZ holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is SABBY MANAGEMENT, LLC's current position in BCTXZ?
As of Q2 2026, SABBY MANAGEMENT, LLC holds 120.80K shares of BCTXZ (BRIACELL THERAPEUTICS CORP), valued at $11.46K, representing 0.08% of its reported portfolio and ranking #18.
Has SABBY MANAGEMENT, LLC been buying or selling BCTXZ?
In the latest 13F filing (Q2 2026), SABBY MANAGEMENT, LLC reduced its position in BCTXZ.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.